| 000 | 01555 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513041633.0 | ||
| 264 | 0 | _c19950601 | |
| 008 | 199506s 0 0 eng d | ||
| 022 | _a0899-1987 | ||
| 024 | 7 |
_a10.1002/mc.2940120406 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrott, D A | |
| 245 | 0 | 0 |
_aNovel use of a selectable fusion gene as an "in-out" marker for studying genetic loss in mammalian cells. _h[electronic resource] |
| 260 |
_bMolecular carcinogenesis _cApr 1995 |
||
| 300 |
_a213-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a3T3 Cells |
| 650 | 0 | 4 |
_a7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aChromosome Deletion |
| 650 | 0 | 4 | _aCloning, Molecular |
| 650 | 0 | 4 | _aDose-Response Relationship, Radiation |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 | _aGenes, Tumor Suppressor |
| 650 | 0 | 4 | _aGenetic Markers |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aNeutrons |
| 650 | 0 | 4 | _aPlasmids |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aProviruses |
| 650 | 0 | 4 | _aRetroviridae |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aCuthbert, A P | |
| 700 | 1 | _aTodd, C M | |
| 700 | 1 | _aThemis, M | |
| 700 | 1 | _aNewbold, R F | |
| 773 | 0 |
_tMolecular carcinogenesis _gvol. 12 _gno. 4 _gp. 213-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/mc.2940120406 _zAvailable from publisher's website |
| 999 |
_c7726414 _d7726414 |
||